Will A Dividend Keep Investors Happy As Amgen Waits For Its Pipeline To Pan Out?
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen outlines its strategic priorities through 2016, but analysts and investors seem more concerned with near-term initiatives that could pan out before year's end.